MSD and Gilead scrap Phase III Trodelvy-Keytruda study on lacklustre interim data
Executive Overview In a significant development for the global oncology landscape, pharmaceutical giants MSD (known as Merck & Co. in...
Archive
Tag: gilead
Hematology & Blood Research
Rethinking High-Risk Acute Promyelocytic Leukemia: A Landmark Meta-Analysis Challenges Decades of Intensive Chemotherapy Dogma
Oncology & Cancer Research
Breaking the Immunotherapy Barrier: University of Chicago Researchers Harness Engineered Probiotics to Tackle Pancreatic Cancer
Oncology & Cancer Research
Decoding the Immune Landscape: How AI and Blood Antibodies Are Revolutionizing Personalized Vaccination Strategies
Clinical Trials & Research
Akeso Doses First Patient in Landmark Phase II Trial Evaluating Novel AK146D1 and Ivonescimab Combination for Advanced Breast Cancer
Toxicology & Pharmacology
Redefining Heart Failure Care: How a Century-Old, Ten-Cent Medication Could Transform Modern Cardiology
Healthcare News & Policy
Raising the Glass: New Insights Into How Beverage Type Alters Alcohol’s Health Risks
Biochemistry & Metabolomics
Unlocking the Triassic: Yale Paleontologists Unearth a New "Dawn-Bringer" Crocodile Relative from a 210-Million-Year-Old Fossil Bed
Pathology & Histology
Unmasking the Fragility of AI: A New Study Reveals Critical Robustness Deficits in Digital Pathology Foundation Models
Precision Medicine
The Metabolic Mind: How Diabetes and Dementia Converge—And How Breakthrough Therapeutics Are Reshaping Neurological Care
Biochemistry & Metabolomics
Unlocking Japan’s Deep-Time Secrets: Overlooked Fossils Reveal Potential New Mosasaur Species After Three Decades in Storage
Clinical Trials & Research
AstraZeneca’s Phase III NSCLC Trial Setback: Re-Evaluating the PD-1 Bispecific Strategy in Advanced Oncology
Healthcare News & Policy
Breaking the Chain of Carcinogenesis: University of Pennsylvania Researchers Develop Bioengineered Chewing Gum to Target Head and Neck Cancer Microbes
